Ken Kobayashi

Experienced drug developer and executive with deep expertise across early and late development, multiple indications (including solid tumors and hematological malignancies), and drugs with many different mechanisms of action. Led highly successful global teams in US and AP regional teams while based in Japan. Moves easily between tactical/executional work at study team level and overall portfolio-level strategy and prioritization work at senior leadership level.”